Oral Interleukin 11 as a countermeasure to lethal total-body irradiation in a murine model

Radiation Research

Volumn 180, Issue 6, 2013, Pages 595-602

  Burnett, Alexander F ^a   Biju, Prabath G ^a   Lui, Huanli ^a   Hauer Jensen, Martin ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITRULLINE; INTERLEUKIN 11; OPRELVEKRIN; RECOMBINANT INTERLEUKIN 11; UNCLASSIFIED DRUG;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL TRANSLOCATION; COLIFORM BACTERIUM; CONTROLLED STUDY; HEMATOPOIETIC CELL; INTESTINE INJURY; INTESTINE MUCOSA; IRRADIATION; LETHAL DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION INJURY; RECOMMENDED DRUG DOSE; SMALL INTESTINE; SURVIVAL; WHOLE BODY RADIATION;

EID: 84891795326     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR13330.1     Document Type: Article

References (25)

1. Augustine AD, Gondre-Lewis T, McBride W, Miller L, Pellmar TC, Rockwell S. Animal models for radiation injury, protection and therapy. Radiat Res 2005; 164, 100-109. (Pubitemid 40885234)
2. Schwertschlag US, Trepicchio WL, Dykstra KH, Keith JC, Turner KJ, Dorner AJ. Hematopoietic, immunomodulatory and epithelial effects of interleukin-11. Leukemia 1999; 13, 1307-1315. (Pubitemid 29429755)
3. Schlerman FJ, Bree AG, Kaviani MD, Nagle SL, Donnelly LH, Mason LE, et al. Thrombopoietic activity of recombinant human interleukin 11 (rHuIL11) in normal and myelosuppressed nonhuman primates. Stem Cells 1996; 14, 517-532. (Pubitemid 26322113)
4. Orazi A, Du X, Yang Z, Kashai M, Williams DA. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest 1996; 75, 33-42. (Pubitemid 26250271)
5. Ropeleski MJ, Tang J, Walsh-Reitz MM, Musch MW, Chang EB. Interleukin-11-induced heat shock protein 25 confers intestinal epithelial-specific cytoprotection from oxidant stress. Gastroenterology 2003; 124, 1358-1368. (Pubitemid 36531810)
6. Potten, CS. Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pretreatment with interleukin 11 also increases murine survival time. Stem Cells 1996; 14, 452-459. (Pubitemid 26286267)
7. Isaacs C, Robert N. J, Bailey FA, Schuster MW, Overmoyer B, Graham M. et al. Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapyinduced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin. J Clin Oncol 1997; 15, 3368-3377. (Pubitemid 27485857)
8. Dykstra KH, Rogge H, Stone A, Loewy J, Keith JC, Jr, Schwertschlag US. Mechanism and amelioration of recombinant human interleukin-11 (rhIL11)-induced anemia in healthy subjects. J Clin Pharmacol 2000; 40, 880-888.
9. Van der Meeren A, Mouthon MA, Gaugler MH, Vandamme M, Gourmelon P. Administration of recombinant human IL11 after supralethal radiation exposure promotes survival in mice: interactive effect with thrombopoietin. Radiat Res 2002; 157, 642-649. (Pubitemid 34569131)
10. Nash RA, Seidel K, Storb R, Slichter S, Schuening FG, Appelbaum FR, et al. Effects of rhIL11 on normal dogs and after sublethal radiation. Exp Hematol 1995; 23, 389-396.
11. Boerma M, Wang J, Burnett AF, Santin AD, Roman JJ, Hauer-Jensen M. Local administration of interleukin-11 ameliorates intestinal radiation injury in rats. Cancer Res 2007; 67, 9501-9506. (Pubitemid 47535940)
12. Baddeley AJ, Gundersen HJ, Cruz-Orive LM. Estimation of surface area from vertical sections. J Microsc 1986; 142, 259-276.
13. Langberg CW, Sauer T, Reitan JB, Hauer-Jensen M. Relationship between intestinal fibrosis and histopathologic and morphometric changes in consequential and late radiation enteropathy. Acta Oncol 1996; 35, 81-87. (Pubitemid 26084855)
14. Withers HR, Elkind MM. Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int J Radiat Biol Relat Stud Phys Chem Med 1970; 17, 261-267.
15. Gupta PK, Brown J, Biju PG, Thaden J, Deutz NE, Kumar S, Hauer-Jensen M, Hendrickson HP. Development of high-throughput HILIC-MS/MS methodology for plasma citrulline determination in multiple species. Anal Meth 2011; 3, 1759-1768.
16. van Minnen LP, Timmerman HM, Lutgendorff F, Verheem A, Harmsen W, Konstantinov SR. et al. Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery 2007; 141, 470-480. (Pubitemid 46441310)
17. DiCarlo AL, Maher C, Hick JL, Hanfling D, Dainiak N, Chao N, et al. Radiation injury after a nuclear detonation: medical consequences and the need for scarce resources allocation. Disaster Med Public Health Prep 2011; 5 Suppl 1, S32-S44.
18. Cotreau MM, Stonis L, Strahs A, Schwertschlag US. A multipledose, safety, tolerability, pharmacokinetics and pharmacodynamic study of oral recombinant human interleukin-11 (oprelvekin). Biopharm Drug Dispos 2004; 25, 291-296. (Pubitemid 39405826)
19. Peterson RL, Bozza MM, Dorner AJ. Interleukin-11 induces intestinal epithelial cell growth arrest through effects on retinoblastoma protein phosphorylation. Am J Pathol 1996; 149, 895-902. (Pubitemid 26334173)
20. Onal C, Kotek A, Unal B, Arslan G, Yavuz A, Topkan E, et al. Plasma citrulline levels predict intestinal toxicity in patients treated with pelvic radiotherapy. Acta Oncol, 2011; 50, 1167-1174.
21. Lutgens LC, Deutz NE, Gueulette J, Cleutjens JP, Berger MP, Wouters BG, et al. Citrulline: a physiologic marker enabling quantitation and monitoring of epithelial radiation-induced small bowel damage. Int J Radiat Oncol Biol Phys 2003; 57, 1067-1074. (Pubitemid 37324125)
22. Lutgens L, Lambin P. Biomarkers for radiation-induced small bowel epithelial damage: an emerging role for plasma Citrulline. World J Gastroenterol 2007; 13, 3033-3042. (Pubitemid 47045459)
23. Ellis M, Zwaan F, Hedstrom U, Poynton C, Kristensen J, Jumaa P. et al. Recombinant human interleukin 11 and bacterial infection in patients with [correction of] haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. Lancet 2003; 361, 275-280. (Pubitemid 36126186)
24. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008; 22, 659-661. (Pubitemid 351348146)
25. Till J. E. McCulloch E. A. Early repair processes in marrow cells irradiated and proliferating in vivo. Radiat Res 1963; 18, 96-105.